RNU1-98P

Across TCGA pan-cancer cohorts, RNU1-98P RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated RNU1-98P data layer.

The strongest signal is observed in pancreatic adenocarcinoma (PAAD), where higher RNU1-98P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU1-98P expression acts as an unfavorable survival marker, although some lineages such as HNSC show a favorable association.

PAAD, LUSC, and THYM are the cancer types where RNU1-98P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PAAD	DFS	Tertile	All	0.202	0.487	.016	36	view →
LUSC	OS	Tertile	II,III,IV	0.541	0.759	.014	21	view →
THYM	DFS	Tertile	II,III,IV	0.621	0.933	.009	18	view →
SARC	OS	Tertile	All	0.174	0.530	.002	18	view →
OV	DFS	Tertile	IV	0.337	0.509	.036	12	view →
PCPG	DFS	Tertile	All	0.161	0.819	.004	9	view →
HNSC	DFS	Tertile	All	0.858	0.686	.032	3	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

RNU1-98P–PAAD (DFS)

Open the PAAD breakdown →